Please assess the completion status of the following clinical trial:

Trial Title: VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Only patients who are medically suitable for corneal refractive surgery can be included in the study.~* Subjects should be 21 years of age or older~* Eyes with high myopia spherical equivalent between -9.00 D up to -14.00 D, with cylinder up to 7.00 D~* The corrected distance visual acuity will be 20/40 or better in each eye pre-operatively~* Calculated sub-lenticule thickness (SLT) ≥220 µm~* Calculated total uncut stromal thickness (TUST) ≥300 µm~* Contact lens wearers must stop wearing their contact lenses at least four weeks per decade of wear before baseline measurements in case of hard contact lenses and one week before baseline measurements in case of soft contact lenses.~* Patient will be able to understand the patient information and willing to sign an informed consent~* Patient will be willing to comply with all follow-up visits and the respective examinations as specified in the flow-chart~Exclusion Criteria:~* Previous intraocular or corneal surgery of any kind on the eye being treated~* Patient not being able to lie flat in a horizontal position~* Patient not being able to tolerate local or topical anesthesia~* Autoimmune diseases~* Sicca syndrome, dry eye~* Herpes viral (herpes simplex) infections~* Herpes zoster~* Diabetes~* Pregnant or nursing women (or who are planning pregnancy during the study)~* Patients with a weight of \> 135 kg~* Any residual, recurrent or acute ocular disease or abnormality of the eye, e.g.~  * Cataract~ * Suspected glaucoma or an intraocular pressure \> 21 mm of Hg~ * Corneal disease~ * Corneal thinning disorder, e.g. keratoconus,~ * Pellucid marginal corneal degeneration~ * Dystrophy of the basal membrane~ * Corneal oedema~ * Exudative macular degeneration~ * Infection~* Any residual, recurrent, or active abnormality of the cornea to be treated, e.g.~  * Existing corneal implant~ * Corneal lesion~ * Unstable refraction~ * Connective tissue disease~ * Dry eye

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Small incision lenticule extraction (Type: EXPERIMENTAL): Patients with high myopia will undergo a SMILE procedure to correct their refraction. Proxymetacaine 0.5% and Oxybuprocaine 0.4% will be used as anaesthetic during the procedure. Tobramycin and dexamethasone, and ofloxacin will be used four times a day for one week after the procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).